Gentium's Defibrotide Brings Sales Record as Launch Looms
Buoyed by the European Medicines Agency's recent reversal of its earlier negative decision on Defitelio (defibrotide), Gentium SpA unveiled its best ever quarter for the product and set out its stall on growing the market, albeit within a narrower indication.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST